Nigeria

Northeast Nigeria Humanitarian Response - COVID-19 Response: Health Sector Bulletin - May 2022

Attachments

Highlights – COVID-19 Vaccination So Far

BORNO STATE:

Total Partially Vaccinated (AstraZeneca, Moderna & Pfizer) = 341,690 which accounts to 10.65% Vaccinated with 1st Dose. Total Fully Vaccinated (AstraZeneca, Moderna, Pfizer & Johnson & Johnson) = 141,530 which accounts to 4.41% fully Vaccinated (Percentage of total 1st doses vaccinated with 2nd doses = 41.42%). Booster Dose Vaccinated (Moderna, Pfizer & Johnson) = 12,377. AstraZeneca: Total Partially Vaccinated with AstraZeneca = 156,111. Total Fully Vaccinated with AstraZeneca = 83,353 (which accounts to 53.39% of 1st dose vaccinated with 2nd dose AstraZeneca). Moderna: Total Partially Vaccinated with Moderna = 67,764. Total Fully Vaccinated with Moderna = 41,076 (which accounts to 60.62% of 1st dose vaccinated with 2nd dose Moderna). Booster Dose Vaccinated with Moderna = 6,649. Pfizer: Total Partially Vaccinated with Pfizer = 51,004. Total Fully Vaccinated with Pfizer = 17,101 (which accounts to 33.53% of 1st dose vaccinated with 2nd dose Pfizer). Booster Dose Vaccinated with Pfizer = 4,925. Johnson & Johnson: Total Fully Vaccinated with Johnson & Johnson = 66,811. Booster Dose Vaccinated with Johnson & Johnson = 803.

YOBE STATE:

Total people vaccinated in the States: 1st dose = 287,545 and percentage coverage per target Population is 13.9%. 2nd dose = 118,645 and percentage coverage per target Population is 5.7%. Moderna 1st dose = 61,206 and 2nd dose = 33,536 with Booster dose = 465; AstraZeneca 1st dose = 121,614 and 2nd dose = 66,225; Pfizer 1st dose = 81,166 and 2nd dose =18,884 with Booster = 4,245; Johnson & Johnson 23,559. Moderna: From 24th August 2021 to 22nd May 2022, a total of 61,206 people had received 1st dose of the Moderna vaccine. Of this number 27,396 were Females and 33,810 were Males. While 33,536 people received 2nd dose of Moderna vaccine, this include 13,146 females and 18,390 Males. Moderna Booster: 465 were vaccinated (282 Males and 183 Female). AstraZeneca: From March 2021 to 22nd May 2022, a total of 121,614 people received 1st dose of the AstraZeneca vaccine (75,928 Males, & 45,686 Female), while 66,225 people had received 2nd dose of AstraZeneca vaccine. Of the doses received, 23,992 were Female and 42,233 Males. Pfizer: A total of 81,166 had received 1st dose, comprises 47,763 Males and 33,403 Females, and only 18,884 people received 2nd dose (10,716 Males and & 8,168 Females). Pfizer Booster: 3,866 were vaccinated (2,305 Males and 1,561 Females). Johnson & Johnson: 1st dose = 23,559 (12,487 Males & 11,072 Females).

ADAMAWA STATE:

During the Mass Vaccination of AstraZeneca, for the 1st phase of AstraZeneca Vaccination, a total of 40,092 came for the 1st dose vaccination and 29,187 came for the second dose vaccination, while during the 2nd phase of AstraZeneca vaccination, a total of 17,430 came for the 1st dose vaccination and 11,300 came for the 2nd dose vaccination, and during the 3rd phase 100,356 came for the 1st dose vaccination and 94,013 came for the 2nd dose vaccination. A total of 376 non-serious AEFI were reported across 18 LGAs of the AstraZeneca 1st dose vaccination and 1 serious AEFI from Guyuk LGA. During the 2nd dose 393 non-serious AEFI were reported from 18 LGAs. During the Phase 2 Moderna Vaccination a total of 33,186 came for the 1st dose vaccination and 28,946 came for the 2nd dose vaccination and during 3rd phase, 20,079 came for the 1st dose and 268,249 came for the 2nd dose vaccination and 158,347 came for the booster vaccination. A total of 135 non-serious AEFI were reported across 16 LGAs of the Moderna 1st dose vaccination and 1 Serious AEFI from Mayo-Belwa. During the 2nd dose, 123 non-serious AEFI were reported from 11 LGAs and the booster vaccination 98 Non-serious AEFI were reported. During the 3 phase for Pfizer Vaccination a total of 174,785 came for the 1st dose vaccination and 111,457 came for the 2nd dose vaccination while 22,100 came for the Booster vaccination. A total of 96 non-serious AEFI were reported across 7 LGAs of the 1st dose Pfizer vaccination, during the 2nd dose Vaccination 55 non-serious AEFI were reported from 6 LGAs. During the booster vaccination 162 non-AEFI were reported from 13 LGAs. During the 3rd Phase Johnson & Johnson Vaccination, 157,986 came for the first dose vaccination while 5,013 came for the 2nd dose of the vaccination. A total of 58 non-serious AEFI were reported from 6 LGAs and 2 serious AEFI as reported from Yola North; 18 during the booster vaccination.